Reset Health welcomes David Plans as Chief Scientific Officer

We’re delighted to welcome David Plans who has joined Reset Health as Chief Scientific Officer (CSO).

With extensive expertise in artificial intelligence and healthcare, David will lead the delivery of Reset Health’s advanced AI strategy and will oversee regulatory compliance with MHRA, FDA, and EU MDR, while directing robust clinical validation studies.

A neuroscientist and technologist, David holds a PhD in AI and Human Behaviour from the University of East Anglia and an MSc in Psychology Research Methods from the University of Surrey. His previous roles include Chief Product and Science Officer at Healios, Head of Research at Huma Therapeutics, and Founder CEO/CPO of BioBeats, a neuroscience and biometrics start up which he successfully exited to Huma.

David has a substantial research funding portfolio and has been published in renowned journals. He has also contributed to patents in biometric health technologies. He has presented at leading industry events and holds a fellowship with the Alan Turing Institute.

David commented: "My goal is to merge cutting-edge AI with clinical insights to transform digital health diagnostics and therapeutics, improving patient outcomes and healthcare efficiency. By developing new AI technologies and fostering strategic partnerships, I aim to position Reset Health as a global leader in AI-driven, biometric-informed personalised healthcare.”